Comparison of Arixtra in Lower Limb Superficial Vein Thrombosis With Placebo - CALISTO

Description:

The goal of the trial was to evaluate treatment with the factor Xa inhibitor fondaparinux (arixtra) compared with placebo among patients with acute symptomatic superficial-vein thrombosis of the legs.